CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
- PMID: 18665147
- DOI: 10.1038/ncponc1183
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
Abstract
Background: A 63-year-old female presented to her primary physician with numbness and weakness in her left leg, which progressed over several days to involve her entire lower extremities. MRI of the spine and brain revealed multiple metastases. The patient received ipilimumab and after 3 months experienced intermittent confusion and focal seizures.
Investigations: Electroencephalogram and MRI scans of the spine and brain, followed by surgical removal of a left frontal cortical brain metastasis and subsequent histological and pathological analyses.
Diagnosis: Metastatic melanoma from an unknown primary tumor.
Management: The patient was treated with ipilimumab on a compassionate-use program and dexamethasone, celecoxib, and levetiracetam to treat the symptoms and seizures. Postoperative stereotactic radiosurgery was initiated.
Similar articles
-
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.Melanoma Res. 2013 Jun;23(3):191-5. doi: 10.1097/CMR.0b013e32835f3d90. Melanoma Res. 2013. PMID: 23462208
-
Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.J Clin Oncol. 2015 Jun 10;33(17):1873-7. doi: 10.1200/JCO.2014.60.1807. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964248
-
Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.Neurosurg Focus. 2015 Mar;38(3):E5. doi: 10.3171/2014.12.FOCUS14698. Neurosurg Focus. 2015. PMID: 25727227
-
Treatment of melanoma metastases in the brain.Semin Surg Oncol. 1996 Nov-Dec;12(6):429-35. doi: 10.1002/(SICI)1098-2388(199611/12)12:6<429::AID-SSU8>3.0.CO;2-C. Semin Surg Oncol. 1996. PMID: 8914207 Review.
-
CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues.Ann Surg Oncol. 2008 Nov;15(11):3014-21. doi: 10.1245/s10434-008-0104-y. Epub 2008 Aug 21. Ann Surg Oncol. 2008. PMID: 18716842 Review.
Cited by
-
Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases.World Neurosurg. 2014 Dec;82(6):1250-5. doi: 10.1016/j.wneu.2013.02.025. Epub 2013 Feb 10. World Neurosurg. 2014. PMID: 23402867 Free PMC article.
-
Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment.Eur J Radiol. 2015 Jul;84(7):1259-68. doi: 10.1016/j.ejrad.2015.03.017. Epub 2015 Mar 23. Eur J Radiol. 2015. PMID: 25937524 Free PMC article. Review.
-
Clinical trial design in brain metastasis: approaches for a unique patient population.Curr Oncol Rep. 2012 Feb;14(1):91-6. doi: 10.1007/s11912-011-0204-x. Curr Oncol Rep. 2012. PMID: 22037882
-
Immunotherapy advances for glioblastoma.Neuro Oncol. 2014 Nov;16(11):1441-58. doi: 10.1093/neuonc/nou212. Epub 2014 Sep 4. Neuro Oncol. 2014. PMID: 25190673 Free PMC article. Review.
-
Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients.Case Rep Oncol Med. 2014;2014:417913. doi: 10.1155/2014/417913. Epub 2014 Jul 1. Case Rep Oncol Med. 2014. PMID: 25105043 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical